BlackRock’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.32B Buy
24,001,675
+222,676
+0.9% +$12.2M 0.03% 530
2025
Q1
$1.68B Buy
23,778,999
+265,883
+1% +$18.8M 0.04% 429
2024
Q4
$1.55B Buy
23,513,116
+889,613
+4% +$58.5M 0.03% 466
2024
Q3
$1.59B Sell
22,623,503
-114,846
-0.5% -$8.07M 0.03% 455
2024
Q2
$1.87B Buy
22,738,349
+8,259,559
+57% +$680M 0.04% 377
2024
Q1
$1.26B Sell
14,478,790
-202,854
-1% -$17.7M 0.03% 513
2023
Q4
$1.42B Buy
14,681,644
+74,457
+0.5% +$7.18M 0.04% 443
2023
Q3
$1.29B Buy
14,607,187
+591,722
+4% +$52.4M 0.04% 437
2023
Q2
$1.21B Sell
14,015,465
-623,111
-4% -$54M 0.03% 465
2023
Q1
$1.42B Buy
14,638,576
+98,385
+0.7% +$9.57M 0.04% 403
2022
Q4
$1.5B Buy
14,540,191
+252,332
+2% +$26.1M 0.05% 380
2022
Q3
$1.21B Sell
14,287,859
-129,242
-0.9% -$11M 0.04% 422
2022
Q2
$1.19B Buy
14,417,101
+459,041
+3% +$38M 0.04% 444
2022
Q1
$1.08B Buy
13,958,060
+56,879
+0.4% +$4.39M 0.03% 553
2021
Q4
$1.23B Sell
13,901,181
-1,419,618
-9% -$125M 0.03% 518
2021
Q3
$1.18B Buy
15,320,799
+2,425,231
+19% +$187M 0.03% 511
2021
Q2
$1.08B Sell
12,895,568
-1,038,589
-7% -$86.7M 0.03% 561
2021
Q1
$1.05B Sell
13,934,157
-780,003
-5% -$58.9M 0.03% 557
2020
Q4
$1.29B Buy
14,714,160
+78,638
+0.5% +$6.9M 0.04% 436
2020
Q3
$1.11B Sell
14,635,522
-1,328,289
-8% -$101M 0.04% 418
2020
Q2
$1.97B Buy
15,963,811
+1,368,101
+9% +$169M 0.08% 234
2020
Q1
$1.23B Buy
14,595,710
+1,537,729
+12% +$130M 0.06% 296
2019
Q4
$1.1B Buy
13,057,981
+157,268
+1% +$13.3M 0.04% 426
2019
Q3
$870M Buy
12,900,713
+40,642
+0.3% +$2.74M 0.04% 481
2019
Q2
$1.1B Buy
12,860,071
+196,702
+2% +$16.8M 0.05% 397
2019
Q1
$1.12B Sell
12,663,369
-915,193
-7% -$81.3M 0.05% 374
2018
Q4
$1.16B Sell
13,578,562
-544,751
-4% -$46.4M 0.06% 317
2018
Q3
$1.37B Buy
14,123,313
+1,002,054
+8% +$97.2M 0.06% 311
2018
Q2
$1.24B Buy
13,121,259
+323,227
+3% +$30.4M 0.06% 328
2018
Q1
$1.04B Sell
12,798,032
-21,712
-0.2% -$1.76M 0.05% 389
2017
Q4
$1.14B Buy
12,819,744
+937,183
+8% +$83.6M 0.05% 348
2017
Q3
$1.11B Buy
11,882,561
+481,601
+4% +$44.8M 0.06% 342
2017
Q2
$1.04B Buy
11,400,960
+335,508
+3% +$30.5M 0.05% 357
2017
Q1
$971M Buy
11,065,452
+10,909,162
+6,980% +$958M 0.05% 362
2016
Q4
$12.9M Buy
156,290
+8,187
+6% +$678K 0.02% 663
2016
Q3
$13.7M Buy
148,103
+10,780
+8% +$997K 0.02% 639
2016
Q2
$10.7M Sell
137,323
-18,261
-12% -$1.42M 0.02% 676
2016
Q1
$12.8M Buy
155,584
+7,276
+5% +$600K 0.02% 601
2015
Q4
$15.5M Buy
148,308
+48,959
+49% +$5.13M 0.02% 581
2015
Q3
$10.5M Sell
99,349
-44,498
-31% -$4.69M 0.02% 615
2015
Q2
$19.7M Sell
143,847
-129,588
-47% -$17.7M 0.03% 511
2015
Q1
$34.1M Buy
273,435
+79,616
+41% +$9.92M 0.05% 403
2014
Q4
$17.5M Sell
193,819
-95,557
-33% -$8.64M 0.03% 558
2014
Q3
$20.9M Sell
289,376
-19,909
-6% -$1.44M 0.03% 493
2014
Q2
$19.2M Sell
309,285
-97,498
-24% -$6.07M 0.03% 511
2014
Q1
$27.7M Buy
406,783
+188,063
+86% +$12.8M 0.04% 424
2013
Q4
$15.4M Buy
218,720
+136,828
+167% +$9.63M 0.03% 568
2013
Q3
$5.91M Buy
81,892
+26,970
+49% +$1.95M 0.01% 724
2013
Q2
$3.06M Buy
+54,922
New +$3.06M 0.01% 832